This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Among the key findings: AI's use in healthcare may reduce administrative burdens and hasten drugdevelopment and clinical diagnosis. However, the report notes that the lack of ubiquitous, uniform standards for medical data and algorithms obstructs system interoperability and data sharing.
This transformation will particularly benefit organizations that can effectively combine AI expertise with traditional pharmaceutical knowledge, creating new competitive advantages in drugdevelopment efficiency, cost management, and market responsiveness.
On the pharma front, expect an emphasis on AI for inventory management and targeted drugdevelopment , plus a shake-up in the market for weight-loss drugs. Read more… 2025 Predictions: Interoperability and Cloud Services. Read more… 2025 Health IT Predictions: Pharma.
Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Interoperability Standards: Support the adoption of standardized data formats and interoperability standards. Regularly assess and update security protocols.
According to an excellent whitepaper describing a case study of Medrec , a platform utilizing blockchain technology, health information interoperability is facilitated with the use of blockchain. However, interestingly, interoperability of blockchain itself remains as much a Holy Grail as interoperability of digital healthcare data.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML-powered solutions are revolutionising healthcare by enabling accurate diagnosis, personalised treatment plans, and efficient drug discovery.
Several key trends and predictions are emerging: Increased focus on digital health and AI: AI-powered diagnostics and drug discovery: Companies specialising in AI-driven medical imaging, genomics analysis, and drugdevelopment are likely to attract significant interest from larger pharmaceutical and technology firms.
Ensuring data accuracy, privacy, and interoperability is crucial. Advancements in Research and DrugDevelopment: Accelerated Drug Discovery: Cognitive architectures can analyse vast amounts of biological and clinical data to identify potential drug targets and accelerate the development of new therapies.
Katherine Seay, Executive Vice President at Clinical Trial Media Diversity in healthcare needs to extend to every corner of the industry, from healthcare practitioners to the drugdevelopment and discovery process. One area where the need for diversity has never been greater is clinical trials.
Challenges and Opportunities While MRA offers immense potential, challenges remain, such as: Data interoperability: Ensuring seamless data exchange between different systems. Emphasis on interoperability: Companies that can facilitate seamless data exchange between different healthcare systems are attracting significant attention.
Enhanced research efficiency: Researchers can gain faster access to anonymized patient data with patient consent through SSI, accelerating research efforts and drugdevelopment. Standardization and adoption: Lack of standardized protocols and widespread adoption by all stakeholders could hinder the technology's potential.
Here are some potential areas of growth: Focus on Interoperability and Integration: As the number of AI tools used in healthcare grows, CAIOs will play a crucial role in ensuring they work seamlessly together. This will involve creating standards for data exchange and promoting the development of interoperable AI platforms.
Boost research and innovation: Researchers will have a secure platform to access and analyse large datasets for medical research, leading to advancements in disease prevention, treatment, and drugdevelopment. This paves the way for establishing the legal framework and technical infrastructure for the data space.
Interoperability and data analytics: Merging companies with expertise in connecting disparate healthcare systems and generating actionable insights can be valuable. Interoperability and data analytics: Merging companies with expertise in connecting disparate healthcare systems and generating actionable insights can be valuable.
Drug discovery: AI-powered tools will accelerate the drugdevelopment process by analyzing vast datasets. Supply chain transparency: Blockchain can track the movement of medical supplies and drugs, ensuring authenticity and reducing counterfeit products.
Dosage Optimisation: AI can optimise drug dosages to minimise side effects and maximize therapeutic benefits. Clinical Trial Enrolment: Patient Matching: Co-pilots can match patients to appropriate clinical trials based on their specific characteristics, accelerating drugdevelopment and improving patient access to innovative treatments.
Accessibility and affordability: Addressing cost barriers and developing affordable pain management solutions for diverse populations. Integration and interoperability: Ensuring smooth integration of new technologies with existing healthcare systems for seamless patient care.
Check out our community’s Healthcare Interoperability and Healthcare Cloud predictions: Sufian Chowdhury, CEO at Kinetik Conquering interoperability will unlock efficiencies. There will be a huge push to unlock efficiency in healthcare, and a key driver will be conquering interoperability.
The Interoperability Year: More Technologies in the Marketplace Drive the Critical Need for Interoperability: In the rapidly evolving landscape of clinical trials and the myriad of technologies going to market, the imperative for interoperability will become increasingly evident.
The task force started by highlighting AIs potential across a long list of use cases, which could have been the tracklist for healthcares greatest hits of 2024: DrugDevelopment – 300+ drug applications contained AI components this year. Ambient AI – Burnout is bad. Patient time is good.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content